Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Doxylamine Succinate,Pyridoxine Hydrochloride
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Analog Pharma Canada Launches its First Product on the Canadian Market
Details : PrALOG-Doxylamine/Pyridoxine is a combination of Doxylamine succinate (an antihistamine) and pyridoxine hydrochloride (vitamin B6) provide anti-nauseant and antiemetic activity.
Product Name : PrALOG
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 09, 2025
Lead Product(s) : Doxylamine Succinate,Pyridoxine Hydrochloride
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Arnica Montana,Dimethyl Sulfone,Pyridoxine Hydrochloride
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Carlin Consumer Health
Deal Size : Undisclosed
Deal Type : Acquisition
Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health
Details : Through the acquisition, Carlin expands its OTC portfolio with Penetrex, a formulation using natural ingredients like Arnica and Vitamin B6 for joint and muscle pain.
Product Name : Penetrex
Product Type : Plant Extract/Herbal
Upfront Cash : Undisclosed
April 30, 2024
Lead Product(s) : Arnica Montana,Dimethyl Sulfone,Pyridoxine Hydrochloride
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Carlin Consumer Health
Deal Size : Undisclosed
Deal Type : Acquisition